FOXO3 Deficiency in Neutrophils Drives Colonic Inflammation and Tumorigenesis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24119730 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jenisha Ghimire und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA. Hauptthemen laut MEDLINE: Colonic Neoplasms, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH R01, Crohn’s & Colitis Foundation.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD), characterized by infiltration of polymorphonuclear neutrophils (PMNs), increases the risk of colon cancer. PMN activation corresponds to the accumulation of intracellular Lipid Droplets (LDs). As increased LDs are negatively regulated by transcription factor Forkhead Box O3 (FOXO3), we aim to determine the significance of this regulatory network in PMN-mediated IBD and tumorigenesis. Affected tissue of IBD and colon cancer patients, colonic and infiltrated immune cells, have increased LDs’ coat protein, PLIN2. Mouse peritoneal PMNs with stimulated LDs and FOXO3 deficiency have elevated transmigratory activity. Transcriptomic analysis of these FOXO3-deficient PMNs showed differentially expressed genes (DEGs; FDR < 0.05) involved in metabolism, inflammation, and tumorigenesis. Upstream regulators of these DEGs, similar to colonic inflammation and dysplasia in mice, were linked to IBD and human colon cancer. Additionally, a transcriptional signature representing FOXO3-deficient PMNs (PMN-FOXO3389) separated transcriptomes of affected tissue in IBD (p = 0.00018) and colon cancer (p = 0.0037) from control. Increased PMN-FOXO3389 presence predicted colon cancer invasion (lymphovascular p = 0.015; vascular p = 0.046; perineural p = 0.03) and poor survival. Validated DEGs from PMN-FOXO3389 (P2RX1, MGLL, MCAM, CDKN1A, RALBP1, CCPG1, PLA2G7) are involved in metabolism, inflammation, and tumorigenesis (p < 0.05). These findings highlight the significance of LDs and FOXO3-mediated PMN functions that promote colonic pathobiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA.
ORCID-Profile: Jenisha Ghimire, Patricia Snarski
Förderung
- NCI NIH HHS
- NIH R01
- Crohn’s & Colitis Foundation
Zitieren
APA
Ghimire, J., Iftikhar, R., Penrose, H. M., Snarski, P., Ruiz, E., & Savkovic, S. D. (2023). FOXO3 Deficiency in Neutrophils Drives Colonic Inflammation and Tumorigenesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119730
Vancouver
Ghimire J, Iftikhar R, Penrose HM, Snarski P, Ruiz E, Savkovic SD. FOXO3 Deficiency in Neutrophils Drives Colonic Inflammation and Tumorigenesis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119730
BibTeX
@article{Ghimire2023,
author = {Ghimire, Jenisha and Iftikhar, Rida and Penrose, Harrison M and Snarski, Patricia and Ruiz, Emmanuelle and Savkovic, Suzana D},
title = {FOXO3 Deficiency in Neutrophils Drives Colonic Inflammation and Tumorigenesis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24119730}
}
EUVIMED